PFSAX
Price
$25.72
Change
+$0.04 (+0.16%)
Updated
Aug 25 closing price
Net Assets
160.14M
RPFGX
Price
$83.27
Change
+$0.01 (+0.01%)
Updated
Aug 25 closing price
Net Assets
1.2B
Interact to see
Advertisement

PFSAX vs RPFGX

PFSAX vs RPFGX Comparison Chart in %
View a ticker or compare two or three
VS
PFSAX vs. RPFGX commentary
Aug 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PFSAX is a StrongBuy and RPFGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RPFGX has more cash in the bank: 1.2B vs. PFSAX (160M). RPFGX pays higher dividends than PFSAX: RPFGX (1.24) vs PFSAX (0.58). PFSAX was incepted earlier than RPFGX: PFSAX (27 years) vs RPFGX (35 years). PFSAX (1.31) is less costly to investors than RPFGX (0.94). PFSAX is a more actively managed with annual turnover of: 31.00 vs. RPFGX (10.00). PFSAX initial investment is less costly to investors than RPFGX (5%) vs RPFGX (5%). PFSAX (1000) and RPFGX (1000) have matching initial minimum investment requirements. RPFGX annual gain was more profitable for investors over the last year : 11.42 vs. PFSAX (2.82). RPFGX return over 5 years is better than : 55.82 vs. PFSAX (14.61).
PFSAXRPFGXPFSAX / RPFGX
Total Expense Ratio1.310.94139%
Annual Report Gross Expense Ratio1.310.94139%
Fund Existence27 years35 years-
Gain YTD9.8844.914201%
Front Load6%5%116%
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets160M1.2B13%
Annual Yield % from dividends0.581.2447%
Returns for 1 year2.8211.4225%
Returns for 3 years52.5181.1165%
Returns for 5 years14.6155.8226%
Returns for 10 years149.66129.53116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PHPSX40.48N/A
N/A
ProFunds Pharmaceuticals UltraSector Svc
USCGX15.70N/A
N/A
Victory Capital Growth
ETCMX15.13N/A
N/A
Eventide Balanced Fund Class C
PRDGX91.21N/A
N/A
T. Rowe Price Dividend Growth
SMMSX29.02N/A
N/A
Invesco Summit S